Could a patient’s own stem cells be used to create insulin-secreting cells, even if that patient has type 1 diabetes?
© Elena Pavlovich/Shutterstock.com
Interesting Endo: T Trials & T1DM Self Care
Our March list includes Testosterone Trials results, self-management in patients transitioning to adult care, and cancer mortality risk with diabetes.
Type 1 Diabetes: First-Ever Exercise Guidelines
A new set of guidelines will help people with type 1 diabetes mellitus exercise safely to avoid fluctuations in blood sugar.
Endo News Roundup: Diabetes Biomarker
March news includes a possible biomarker for diabetes, a new sensor to read glucose levels, and a study on insulin resistance and bone fracture.
Top 8 Endocrinology Apps
Eight top apps for endocrinologists include decision support tools, printable patient handouts, calculators, and treatment guidelines.
Glycemic Control: CGM vs Self-Monitoring
The study also compared psychosocial variables, including treatment satisfaction, well-being, and fear of hypoglycemia, during CGM vs self-monitoring.
Interesting Endo: Fracture Risk & Type 1 Management
Our February list includes bone events with thyroid cancer, treatment comparison of Graves’ disease, and exercise recommendations for type 1 diabetes.
Type 1 Diabetes and the Microbiome
The authors compared biopsies of the duodenal mucosa in patients with type 1 diabetes, celiac disease, and controls.
CV Risks and Diabetes: Puerto Rican Population
Dr. Bobby Lazzara discusses a study looking at certain demographics and cardiovascular complications in a diabetic patient population in Puerto Rico.
Safety of Closed-Loop Insulin Delivery System
Dr. Bobby Lazzara reviews the safety of a hybrid closed-loop insulin delivery system for patients with type 1 diabetes in a real-world setting.
Metformin: Cardioprotective in Type 1 Diabetes?
Can metformin’s cardioprotective effect also benefit patients with type 1 diabetes? Dr. Bobby Lazzara discusses a small study of 23 patients.
By clicking Accept, you agree to become a member of the UBM Medica Community.